AzTrials
AzTrials

Clinical CompetenceCC-TrainedNCT06844097

Intervention for Medical Student to Promote Cervical Cancer Screening Among Latinx Transmasculine Individuals

A study testing Cervical Cancer Trans Inclusive Education (CC-TRAINED) Module and Disaster Preparedness Course in people with Clinical Competence and Medical Education, run by Ponce Medical School Foundation, Inc..

Not yet recruiting

Opening soon. The study is approved but enrolment has not started yet. Sites may already take enquiries.

Sites and contacts
Official record
Search all trials

Trial summary

The team aims to test the effectiveness of an intervention to increase gender-affirming cervical cancer prevention behaviors targeted at medical students studying in Puerto Rico and Florida. Read more about this study

Who is it for?
Ages 21 years and older
What is being tested?
Cervical Cancer Trans Inclusive Education (CC-TRAINED) Module and Disaster Preparedness Course
Could I receive a placebo?
No, everyone receives an active treatment
How many people
60 participants
Where
No sites listed yet
Study dates
7 Apr 2025to 31 Aug 2026
Phase
Interventional
Are there results?
Not yet: the study is under way

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 21 years and older
  • All sexes
  • No healthy volunteers
  • Adult, Older adult

Who may be able to join

  • Medical student currently in third year of medical school training

Who cannot join

  • Do not speak English

Trial locations and contacts

No sites are listed yet. Contact the study team or a site near you to ask about taking part.

Alixida Ramos-Pibernus, PhD contact

787-840-2575

aliramos@psm.edu

Matthew B Schabath, PhD contact

813-745-4150

matthew.schabath@moffitt.org

About this study

Official title: Testing the Effectiveness of an Intervention to Foster Cervical Cancer Screening Promotion for Latinx Trans Men Among Medical Students

The team aims to test the effectiveness of an intervention to increase gender-affirming cervical cancer prevention behaviors targeted at medical students studying in Puerto Rico and Florida. The team expects that after exposure to the intervention, relative to the control group, participants in the experimental condition will manifest more favorable changes in knowledge, attitudes, and behaviors of adequate care towards Latinx transmasculine and non-binary people.

Read the detailed description

Transmen (TM) and non-binary individuals (NB; individuals assigned female sex at birth who identify as a man, male, or another diverse non-binary gender identity on the masculine spectrum) are at higher risk of screening-detectable cancers. Latinx TM-NB (LTM-NB) are at a higher risk for cervical cancer (CC) as they intersect two health disparity populations with high risk for this type of cancer (gender identity and ethnic minorities). Despite CC being highly preventable, LTM-NB individuals have been found to have lower rates of CC screening than cisgender female patients (persons who are not transgender). Unfortunately, findings from the team's previous funded studies with LTM-NB individuals in Puerto Rico (PR) and Florida evidence that providers lack knowledge regarding LTM-NB individual's healthcare needs, have negative stigmatizing attitudes, and manifest discriminatory behaviors in clinical interactions with LTM-NB individuals; which greatly limits their ability for engaging in recommended education and prevention guidelines of care for CC screening and prevention. In light of this, the research team (community stakeholders from PR and Mainland US, researchers, and providers) has developed a brief online intervention to improve medical students' competencies for cervical cancer education and screening promotion among LTM-NB individuals.

The proposed study aims to: 1) Test the effectiveness of the intervention in increasing medical students' knowledge, attitudes, and skills for providing healthcare to LTM-NB. , 2) Determine the acceptability, appropriateness, and feasibility of implementing the interventions in real-world medical educational settings.

While the team has preliminary data regarding the efficacy of the intervention, this pilot is proposing a rigorous study design: Aim 1 will measure the magnitude of effect of the intervention, and Aim 2 measures the implementation. This study will address cervical cancer disparities among LTM-NB individuals. The impact of this study will reveal new effective interventions and implementation strategies. The translational implications of this work will result in providing medical schools with a cross-cultural tool to train students on cervical cancer prevention for LTM-NB individuals.

Being tested
Cervical Cancer Trans Inclusive Education (CC-TRAINED) Module, Disaster Preparedness Course
Keywords
Latinx transmaculine, Latinx Non-Binary, Medical Students, SGM Cancer Research, Efficacy Study, Cervical Cancer Prevention Intervention

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • Cervical Cancer Trans Inclusive Education (CC-TRAINED) ModuleBehavioural

    An online course designed to increase cervical cancer prevention clinical skills among medical students when working with Latinx transmasculine populations.

  • Disaster Preparedness CourseBehavioural

    An online course designed to improve professionals' skills and competencies for engaging in disaster preparedness.

Study groups in NCT06844097
Study groupRoleWhat they receive
Cervical Cancer Trans Inclusive Education (CC-TRAINED) ModuleExperimentalParticipants assigned to the experimental condition will receive the CC-TRAINED intervention.
Receives: Behavioral: Cervical Cancer Trans Inclusive Education (CC-TRAINED) Module
Disaster Preparedness CourseOtherParticipants randomized to the control condition will receive a Disaster Preparedness Course, addressing the basics of natural disaster preparedness
Receives: Behavioral: Disaster Preparedness Course

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Change cervical cancer preventive behaviors, as determined by the Cervical Cancer Preventive Behaviors Inventory

    The CCPBI includes 46 non-verbal and verbal behaviors that can be manifested during the SPS interactions with LTM. The team expects that following intervention exposure, relative to control group participants, intervention participants will manifest a higher mean number of CC preventive behaviors on the CCPBI outcome.

    Measured: Baseline, immediately after the intervention

  2. Change in LTMNB knowledge, as determined by Transmasculine knowledge index

    This measure assesses health professionals' knowledge of TM-specific health issues. Intervention participants, relative to controls, will have a higher mean knowledge (literacy) level regarding LTM issues.

    Measured: Baseline, immediately after the intervention

  3. Change negative attitudes towards LTMNB, as determined by the transgender stigma scale

    This scale measures stigma related to transgender identity among healthcare providers. Intervention participants, relative to controls, will have a lower mean level of stigmatizing attitudes toward LTM

    Measured: Baseline, immediately after the intervention

  4. Change negative and increase positive emotions related to LTMNB, as determined by the Emotional Reactions Scale

    This scale measures emotional reactions to LTMNB. Intervention participants, relative to control participants, will have an increase in the mean of positive emotions, and a reduction in the mean level of negative emotions.

    Measured: Baseline, immediately after the intervention

  5. Change cultural humility, as determined by the cross-cultural scale

    This adaptation of the Cross-Cultural Care Scale55 measures cultural humility preparedness and skills towards multiple identities. Intervention participants, relative to control participants, will have an increase in the mean of cultural humility.

    Measured: Baseline, immediately after the intervention

Secondary outcomes (1)
  1. Sex as a biological variable

    Following NIH guidance regarding investigating differential effects of sex and gender, we will repeat all analyses twice, stratified by a) sex at birth and b) current gender identification, respectively.

    Measured: Baseline, immediately after the intervention

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted25 Feb 2025
  2. Study start7 Apr 2025 (estimated)
  3. Primary completion31 Aug 2026 (estimated)
  4. Study completion31 Aug 2026 (estimated)

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase N/A
Primary purpose
Prevention
Allocation
Randomised
Intervention model
Parallel groups
Masking
None (open label)
Enrolment
60 participants (estimated)
IDs, dates and publications
ClinicalTrials.gov ID
NCT06844097
Sponsor's protocol ID
2308159535R001
Other IDs
2U54CA163071-11
Acronym
CC-Trained
Status last verified
Feb 2025
First submitted
19 Feb 2025
Last updated
4 Mar 2025
Results posted
No
Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
Individual data sharing
No

Questions about this trial

What is this clinical trial studying?

A study testing Cervical Cancer Trans Inclusive Education (CC-TRAINED) Module and Disaster Preparedness Course in people with Clinical Competence and Medical Education, run by Ponce Medical School Foundation, Inc..

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 1 inclusion and 1 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: opening soon, as of the sponsor's last update on 4 Mar 2025. Status can change between updates, so confirm with the study contact before making plans.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

This study is still under way. Results are not available in the source record yet.

How can a doctor refer a patient or contact the research team?

Contact Alixida Ramos-Pibernus, PhD (787-840-2575, aliramos@psm.edu), or a site near the patient. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Change cervical cancer preventive behaviors, as determined by the Cervical Cancer Preventive Behaviors Inventory (time frame: Baseline, immediately after the intervention). The study lists 5 primary outcomes in all. It is what the study was designed to measure, not a finding.

Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 4 Mar 2025.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in